Shanehsaz, S.M. and Ishkhanian, S. 2016. Therapeutic and adverse effects of standard-dose and low-dose meglumine antimoniate during systemic treatment of Syrian cutaneous leishmaniasis patients. Journal of Pakistan Association of Dermatologists. 24, 2 (Dec. 2016), 115–121.